Skip to content
céfixime

Structure via PubChem · Public domain (PubChem)

EntityQ163901· pop 31· linked from 213 articles

Also known as CL-284635, FK-027, FR-17027, cefixime anhydrous, (−)-cefixime, suprax

composé chimique

Key facts

Drug.Verifiedfields
changed
Drug.Watchedfields
changed
Drug.verifiedrevid
460023156
Drug.image
Cefixime skeletal structure.svg
Drug.image_class
skin-invert-image
Drug.image2
Cefixime ball-and-stick model from xtal 2013.png
Drug.image_class2
bg-transparent
Drug.tradename
Suprax, others
Drug.MedlinePlus
a690007
Drug.DailyMedID
Cefixime
Drug.routes_of_administration
By mouth
Drug.ATC_prefix
J01
Drug.ATC_suffix
DD08
Drug.legal_CA
Rx-only
Drug.legal_UK
POM
Drug.legal_US
Rx-only
Drug.legal_status
Rx-only
Drug.bioavailability
30 to 50%

via Wikipedia infobox

Chemical data

Formula
C16H15N5O7S2
Molecular weight
453.5 g/mol
IUPAC name
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
SMILES
C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O
InChIKey
OKBVVJOGVLARMR-QSWIMTSFSA-N
XLogP
-0.7
Polar surface area
238 Ų
H-bond donors
4
H-bond acceptors
12
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
1989
Admin. routes
oral
Indications
Otitis media, infection, neoplasm, osteomyelitis

via ChEMBL · EBI

Wikidata facts

Mass
453.04128982000003
Has use
medication
Show 9 more facts
chemical formula
C₁₆H₁₅N₅O₇S₂
subject has role
enzyme inhibitor
medical condition treated
otitis media
canonical SMILES
C=CC1=C(N2C(C(C2=O)NC(=O)C(=NOCC(=O)O)C3=CSC(=N3)N)SC1)C(=O)O
isomeric SMILES
C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O
World Health Organisation international non-proprietary name
cefixime
NCI Thesaurus ID
C1100
defined daily dose
0.4
Commons category
Cefixime
Sources (7)

via Wikidata · CC0

Article · Français

Le céfixime est une molécule antibiotique. C’est une céphalosporine de troisième génération, commercialisée en France en tant que médicament générique ou sous le nom d’Oroken (ou Ofiken). C’est l’une des seules molécules de sa classe (C3G) à être utilisable par voie orale (avec le cefpodoxime).

Abstract from DBpedia / Wikipedia · CC BY-SA